Evotec SE (LON:0IRF)
London · Delayed Price · Currency is GBP · Price in EUR 5.87
-0.14 (-2.33%)
At close: Feb 12, 2026
Evotec SE Revenue
In the year 2024, Evotec SE had annual revenue of 796.97M EUR with 1.99% growth. Evotec SE had revenue of 163.89M in the quarter ending September 30, 2025, a decrease of -5.75%.
Revenue
796.97M EUR
Revenue Growth
+78.52%
P/S Ratio
1.36
Revenue / Employee
166.45K EUR
Employees
4,788
Market Cap
899.95M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 796.97M | 15.54M | 1.99% |
| Dec 31, 2023 | 781.43M | 29.98M | 3.99% |
| Dec 31, 2022 | 751.45M | 250.52M | 50.01% |
| Dec 31, 2020 | 500.92M | 54.49M | 12.20% |
| Dec 31, 2019 | 446.44M | 71.03M | 18.92% |
| Dec 31, 2018 | 375.41M | 334.83M | 825.21% |
| Dec 31, 2006 | 40.58M | -1.26M | -3.02% |
| Dec 31, 2005 | 41.84M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kier Group | 4.08B |
| Pets at Home Group | 1.47B |
| Senior | 986.60M |
| CVS Group | 673.20M |
| Genuit Group | 586.70M |
| Elementis | 534.36M |
| CMC Markets | 347.21M |
| Jupiter Fund Management | 344.30M |
Evotec SE News
- 5 weeks ago - Evotec SE (EVO) Secures Gates Foundation Grant for Biotherapeutics - GuruFocus
- 5 weeks ago - Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access - Accesswire
- 5 weeks ago - Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations - Accesswire
- 2 months ago - Evotec: How Low A Company May Go While Still Being Attractive - Seeking Alpha
- 2 months ago - Sandoz Completes Acquisition Of Just-Evotec Biologics - Nasdaq
- 2 months ago - Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz - Accesswire
- 2 months ago - Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome - Accesswire
- 3 months ago - Evotec (EVO) Secures $5M Milestone from Bristol Myers Squibb - GuruFocus